A Massively Parallel Fluorescence Assay to Characterize the Effects of Synonymous Mutations on TP53 Expression

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular Cancer Research

• Publication date

  2017-06-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-17-0245PMID 28652265PMCID PMC5626615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

  2017cited by this paper
• TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions

  2016cited by this paper
• Learning the sequence determinants of alternative splicing from millions of random sequences.

  2015cited by this paper
• Analysis of protein-coding genetic variation in 60,706 humans

  2015cited by this paper
• The Silent Sway of Splicing by Synonymous Substitutions*

  2015cited by this paper
• Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

  2015cited by this paper
• A general framework for estimating the relative pathogenicity of human genetic variants

  2014influential reference
• Deep mutational scanning: a new style of protein science

  2014cited by this paper
• p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state

  2014cited by this paper
• RNase-mediated protein footprint sequencing reveals protein-binding sites throughout the human transcriptome

  2014cited by this paper
• COSMIC: exploring the world's knowledge of somatic mutations in human cancer

  2014cited by this paper
• Synonymous mutations frequently act as driver mutations in human cancers.

  2014influential reference
• Composability of regulatory sequences controlling transcription and translation in Escherichia coli

  2013cited by this paper
• Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma

  2013cited by this paper
• Deep mutational scanning of an RRM domain of the Saccharomyces cerevisiae poly(A)-binding protein

  2013cited by this paper
• Cancer Genome Landscapes

  2013cited by this paper
• A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease

  2011cited by this paper
• ViennaRNA Package 2.0

  2011cited by this paper
• Understanding the contribution of synonymous mutations to human disease

  2011cited by this paper
• Enrich: software for analysis of protein function by enrichment and depletion of variants

  2011cited by this paper
• Haplo‐insufficiency: a driving force in cancer

  2011cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• Enzymatic assembly of DNA molecules up to several hundred kilobases

  2009cited by this paper
• Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

  2007cited by this paper
• A suite of Gateway® cloning vectors for high‐throughput genetic analysis in Saccharomyces cerevisiae

  2007cited by this paper
• A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes.

  2006cited by this paper
• Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers.

  2006cited by this paper
• Listening to silence and understanding nonsense: exonic mutations that affect splicing

  2002cited by this paper
• p53 function and dysfunction.

  1992cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper

• Ensemble learning-based predictor for driver synonymous mutation with sequence representation

  2025cites this paper
• Synonymous and non-synonymous variants at splice junctions can disrupt splicing and are frequently linked to disease associated loss of function genes

  2025cites this paper
• Mis-splicing drives loss of function of p53E224D point mutation

  2025cites this paper
• Functional characterization of 2,832 JAG1 variants supports reclassification for Alagille syndrome and improves guidance for clinical variant interpretation

  2024cites this paper
• Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice

  2023cites this paper
• Mis-splicing Drives Loss of Function of p53E224D Point Mutation

  2023cites this paper
• Nonsynonymous Synonymous Variants Demand for a Paradigm Shift in Genetics

  2023cites this paper
• Genetic differences between smokers and never-smokers with lung cancer

  2023cites this paper
• Synonymous Variants: Necessary Nuance in our Understanding of Cancer Drivers and Treatment Outcomes.

  2022cites this paper
• Codon optimality is the primary contributor to the exceptional mutational sensitivity of CcdA antitoxin in its operonic context

  2022cites this paper
• Analyses of HIV proteases variants at the threshold of viability reveals relationships between processing efficiency and fitness

  2021cites this paper
• Prioritizing genes for systematic variant effect mapping

  2020cites this paper
• Loss of function from widely distributed, synonymous mutations at single codons

  2019influential citation
• MaveDB: an open-source platform to distribute and interpret data from multiplexed assays of variant effect

  2019cites this paper
• Functional assays for transcription mechanisms in high-throughput.

  2019cites this paper
• “Lost in translation: Seeing the forest by focusing on the trees”

  2018cites this paper
• Cancer subtype identification using somatic mutation data

  2017cites this paper